文献速递头颈外科

2001至2017年美国全部50个州口咽癌发病与死亡趋势

Oropharyngeal Cancer Incidence and Mortality Trends in All 50 States in the US, 2001-2017.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2022-01-01

这项横断面研究利用美国癌症统计数据分析了2001至2017年美国50州及哥伦比亚特区口咽癌发病趋势,并评估了基于发病的死亡趋势。全国共识别260182例口咽癌,男性发病每年增长2.7%,65岁及以上及非西班牙裔白人男性增长显著,区域期病变近2倍增加,男性近年基于发病的死亡率每年上升2.1%,而女性死亡变化为-1.2%(95%CI -2.5%至0.1%)。

要点

  • 2001至2017年全国共260182例口咽癌,80%为男性,65%为区域期,55%在东南与中西部。
  • 男性口咽癌发病每年增长2.7%,区域期发病每年增长3.1%(95%CI 2.4%至3.8%),近2倍增加。
  • 男性基于发病的死亡率近年(2006至2017年)每年上升2.1%(95%CI 1.0%至3.2%),女性为-1.2%(95%CI -2.5%至0.1%)。

核心结论

  • 研究提示美国男性口咽癌发病率持续上升,老年人群增长迅速。
  • 区域期口咽癌明显增加及男性近期死亡率上升令人担忧,亟需加强预防。
  • 中西部和东南部呈现明显地理聚集,提示需针对性预防并开展未来研究以理解地理差异的病因。

研究设计与样本

  • 横断面研究,使用美国癌症统计数据评估2001至2017年口咽癌发病趋势。
  • 观察死亡趋势使用国家卫生统计中心数据,基于发病的死亡趋势使用监测、流行病学和最终结果(SEER)项目数据。
  • 数据分析于2021年1月至4月进行。

主要发现

  • 全国共识别260182例口咽癌,其中男性209297例(80%),区域期168674例(65%),东南和中西部142068例(55%)。
  • 男性口咽癌发病全国每年增长2.7%,非西班牙裔白人男性及65岁及以上男性年增长超过3%。
  • 女性总体年度百分比变化为0.5%(95%CI -0.28%至1.22%)。
  • 男性区域期口咽癌发病每年增长3.1%(95%CI 2.4%至3.8%),近2倍增加;女性区域期每年增长1.0%(95%CI 0.3%至1.7%)。
  • 男性除阿拉斯加、哥伦比亚特区和怀俄明外所有州和地区发病均增加,东南和中西部年增长超过3.5%;女性年增长超过2%也集中在东南和中西部。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Oropharyngeal cancer (OPC) incidence is rising among men in the US. Comprehensive assessments of nationwide trends in OPC incidence and mortality by demographics, tumor characteristics at diagnosis, and geography are lacking. OBJECTIVE: We examined secular trends in OPC incidence and mortality rates in all 50 US states and the District of Columbia (DC). DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional study, we used the US Cancer Statistics data set to examine OPC incidence trends from 2001 through 2017. Observed and incidence-based mortality trends were evaluated using data from the National Center for Health Statistics and Surveillance Epidemiology and End Results program, respectively. Data analysis was conducted from January to April 2021. RESULTS: Nationwide, 260 182 OPC cases were identified; 209 297 (80%) occurred in men, 168 674 (65%) with regional stage, and 142 068 (55%) in the Southeast and Midwest regions, during 2001 to 2017. Incidence of OPC increased nationally 2.7% per year among men, with a notable (over 3% per year) rise among non-Hispanic White men and in men aged 65 years and older. Overall, among women, the annual percentage change was 0.5% (95% CI, -0.28% to 1.22%). Among men, with a 3.1% per year rise (95% CI, 2.4% to 3.8%), regional-stage OPC incidence increased nearly 2-fold. Among women, regional-stage OPC incidence increased 1.0% per year (95% CI, 0.3% to 1.7%). Among men, OPC incidence increased in all states and regions except Alaska, DC, and Wyoming. Among men, the most pronounced increases (more than 3.5% per year) were clustered in the Southeast and Midwest regions. Among women, a rise of more than 2% per year was also concentrated in the Southeast and Midwest regions. Among men, OPC incidence-based mortality increased 2.1% per year (95% CI, 1.0% to 3.2%) overall in recent years (from 2006 to 2017). In contrast, among women, the annual percentage change in OPC incidence-based mortality was -1.2% (95% CI, -2.5% to 0.1%). CONCLUSIONS AND RELEVANCE: The findings of this cross-sectional study suggest that the incidence of OPC has continued to increase nationally among men in the US, with rapid increases among the elderly population. The notable rise in regional-stage OPC and the concurrent recent rise in mortality among men is troubling and calls for urgent improvements in prevention. Distinct geographic patterns with notable rises in the Midwest and Southeast regions imply the need for improved and targeted prevention as well as future studies to understand etiological reasons for geographic disparities.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Damgacioglu H, Sonawane K, Zhu Y, et al. Oropharyngeal Cancer Incidence and Mortality Trends in All 50 States in the US, 2001-2017. JAMA Otolaryngol Head Neck Surg. 2022. PMID: 34913945. doi:10.1001/jamaoto.2021.3567

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。